NO861956L - Fremgangsmaate for fremstilling av askorbinsyrederivater. - Google Patents
Fremgangsmaate for fremstilling av askorbinsyrederivater.Info
- Publication number
- NO861956L NO861956L NO861956A NO861956A NO861956L NO 861956 L NO861956 L NO 861956L NO 861956 A NO861956 A NO 861956A NO 861956 A NO861956 A NO 861956A NO 861956 L NO861956 L NO 861956L
- Authority
- NO
- Norway
- Prior art keywords
- procedure
- preparation
- ascorbic acid
- acid derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1985/000272 WO1986006720A1 (en) | 1985-05-17 | 1985-05-17 | Ascorbic acid derivatives, production thereof, and pharmaceutical preparation therefrom |
| PCT/JP1985/000340 WO1986007592A1 (en) | 1985-06-18 | 1985-06-18 | Ascorbic acid derivatives, process for their preparation, and preparations containing same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO861956L true NO861956L (no) | 1986-11-18 |
| NO172343B NO172343B (no) | 1993-03-29 |
| NO172343C NO172343C (no) | 1993-07-07 |
Family
ID=26425982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO861956A NO172343C (no) | 1985-05-17 | 1986-05-16 | Analogifremgangsmaate for fremstilling av terapeutisk aktive askorbinsyrederivater |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0202589B1 (no) |
| JP (1) | JPH0739342B2 (no) |
| KR (1) | KR940000073B1 (no) |
| CN (1) | CN1014409B (no) |
| AU (1) | AU599029B2 (no) |
| CA (1) | CA1293728C (no) |
| DE (1) | DE3669104D1 (no) |
| ES (1) | ES8801643A1 (no) |
| FI (1) | FI862029A (no) |
| GR (1) | GR861228B (no) |
| HU (1) | HU197735B (no) |
| IE (1) | IE59143B1 (no) |
| IL (1) | IL78739A (no) |
| NO (1) | NO172343C (no) |
| PH (1) | PH24833A (no) |
| PT (1) | PT82591B (no) |
| ZA (1) | ZA852614B (no) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2515556B2 (ja) * | 1986-08-29 | 1996-07-10 | 武田薬品工業株式会社 | ヒドロキシブテノライド誘導体およびその製造法 |
| US4826872A (en) * | 1986-12-03 | 1989-05-02 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition for treatment of cataract |
| PH25859A (en) * | 1988-01-11 | 1991-12-02 | Takeda Chemical Industries Ltd | Composition for treatment of ischemic disorder |
| JPH01228978A (ja) * | 1988-03-09 | 1989-09-12 | Nippon Hai Potsukusu:Kk | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
| JP2752080B2 (ja) * | 1988-03-09 | 1998-05-18 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びその製造方法並びにアスコルビン酸誘導体からなる抗酸化剤 |
| JPH0730066B2 (ja) * | 1988-03-09 | 1995-04-05 | 株式会社日本ハイポックス | アスコルビン酸誘導体及びアスコルビン酸誘導体からなる抗酸化剤 |
| US4939128A (en) * | 1988-04-25 | 1990-07-03 | Takeda Chemical Industries, Ltd. | Ester of ascorbic acid 2-phosphate and pharmaceutical use |
| JP2830268B2 (ja) * | 1989-01-21 | 1998-12-02 | 武田薬品工業株式会社 | アスコルビン酸誘導体の製造法 |
| EP0446539A1 (en) * | 1990-03-16 | 1991-09-18 | Merrell Dow Pharmaceuticals Inc. | Novel ascorbic acid derivatives |
| US5270336A (en) * | 1990-03-16 | 1993-12-14 | Merrell Dow Pharmaceuticals Inc. | Ascorbic acid derivatives |
| EP0467691A1 (en) * | 1990-07-20 | 1992-01-22 | Takeda Chemical Industries, Ltd. | Saccharoascorbic acid derivatives and their use |
| WO1993004055A2 (en) * | 1991-08-27 | 1993-03-04 | The Upjohn Company | Compounds used for the inhibition of hiv-protease |
| JPH0656669A (ja) * | 1992-06-11 | 1994-03-01 | Asahi Breweries Ltd | 活性酸素消去作用を持つプテリン誘導体製剤 |
| TW325997B (en) * | 1993-02-02 | 1998-02-01 | Senju Pharma Co | Pharmaceutical composition for preventing and treating retinal diseases |
| US5977169A (en) * | 1993-09-17 | 1999-11-02 | Chrusciel; Robert A. | Substituted tetronic acids useful for treating HIV and other retroviruses |
| JPH07188024A (ja) * | 1993-12-27 | 1995-07-25 | Asahi Breweries Ltd | 脳循環障害治療剤 |
| FR2715156B1 (fr) * | 1994-01-20 | 1996-03-01 | Oreal | Mono-esters d'acide cinnamique ou de ses dérivés et de vitamine C, leur procédé de préparation et leur utilisation comme anti-oxydants dans des compositions cosmétiques, pharmaceutiques ou alimentaires. |
| US6060600A (en) * | 1995-03-20 | 2000-05-09 | Pharmacia & Upjohn Company | Substituted tetronic acids useful for treating HIV and other retroviruses |
| WO1996030012A1 (en) * | 1995-03-24 | 1996-10-03 | Defeudis Francis V | Methods for treating conditions associated with excess nitric oxide |
| GB2321455A (en) * | 1997-01-24 | 1998-07-29 | Norsk Hydro As | Lipophilic derivatives of biologically active compounds |
| KR100440190B1 (ko) * | 2001-08-23 | 2004-07-12 | 박관화 | 아카비오신-글루코실 아스코르베이트 및 그의 제조방법 |
| KR100440191B1 (ko) * | 2001-08-23 | 2004-07-12 | 박관화 | 항산화 효과 및 높은 안정성을 갖는 아스코르브산 유도체및 그것의 제조방법 |
| EP1620419A4 (en) * | 2003-04-21 | 2008-07-23 | Tagra Biotechnologies Ltd | STABILIZED DERIVATIVES OF ASCORBIC ACID |
| FR2946252B1 (fr) * | 2009-06-08 | 2011-07-29 | Fabre Pierre Dermo Cosmetique | Bis esters d'acide gras insature sur l'acide ascorbique et leurs utilisations cosmetiques |
| JP6020447B2 (ja) * | 2011-05-18 | 2016-11-02 | 三菱瓦斯化学株式会社 | 酸素吸収剤 |
| FR2978963A1 (fr) | 2011-08-11 | 2013-02-15 | Ascorbix | Nouveaux derives des furanones et composition pharmaceutique les contenant |
| EP2902387A1 (en) * | 2012-09-27 | 2015-08-05 | Nippon Soda Co., Ltd. | Ascorbic acid-related compound and anti-plant-virus agent |
| US10836844B2 (en) | 2015-12-03 | 2020-11-17 | 3M Innovative Properties Company | Redox polymerizable composition with photolabile reducing agents |
| CN110709486B (zh) * | 2017-05-24 | 2021-04-16 | 3M创新有限公司 | 粘合剂制品及其制造和使用方法 |
| JP6986375B2 (ja) * | 2017-06-22 | 2021-12-22 | 章博 田井 | 抗アレルギー剤、メディエーター遊離阻害剤及び内服薬 |
| JP7140325B2 (ja) | 2018-05-23 | 2022-09-21 | 株式会社らいむ | 化合物、抗アレルギー剤およびメディエーター遊離阻害剤 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1016834A (en) * | 1962-11-26 | 1966-01-12 | Nihon Surfactant Ind Company L | Improvements in or relating to 2.6 diesters of ascorbic acid or isoascorbic acid |
| DE1518988A1 (de) * | 1965-05-07 | 1969-12-11 | Herbert Ohg A | Verfahren zur Herstellung von Di- und Triestern der Ascorbinsaeure |
| JPS49833B1 (no) * | 1970-09-01 | 1974-01-10 | ||
| JPS4867268A (no) * | 1971-12-20 | 1973-09-13 | ||
| JPS5719109B2 (no) * | 1973-07-19 | 1982-04-20 | ||
| US4164585A (en) * | 1976-07-01 | 1979-08-14 | Cardioquest Corporation | Anti-thrombotic compound and method of making and using the same for pharmaceutical purposes |
| JPS5692260A (en) * | 1979-12-26 | 1981-07-25 | Nippon Chemiphar Co Ltd | Cyclohexanecarboxylic ester and its preparation |
| JPS57156479A (en) * | 1981-03-24 | 1982-09-27 | Santen Pharmaceut Co Ltd | Ascorbic acid derivative |
| JPS601175A (ja) * | 1983-06-16 | 1985-01-07 | Daikin Ind Ltd | アスコルビン酸誘導体 |
| JPS6023307A (ja) * | 1983-07-15 | 1985-02-05 | Kanebo Ltd | 美白化粧料 |
| JPS60130582A (ja) * | 1983-12-19 | 1985-07-12 | Takeda Chem Ind Ltd | 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法 |
| JPS60237083A (ja) * | 1984-05-08 | 1985-11-25 | Kao Corp | アスコルビン酸エステル |
-
1985
- 1985-04-09 ZA ZA852614A patent/ZA852614B/xx unknown
-
1986
- 1986-05-09 IL IL78739A patent/IL78739A/xx not_active IP Right Cessation
- 1986-05-12 AU AU57350/86A patent/AU599029B2/en not_active Ceased
- 1986-05-12 GR GR861228A patent/GR861228B/el unknown
- 1986-05-13 PH PH33764A patent/PH24833A/en unknown
- 1986-05-14 DE DE8686106521T patent/DE3669104D1/de not_active Expired - Fee Related
- 1986-05-14 FI FI862029A patent/FI862029A/fi not_active Application Discontinuation
- 1986-05-14 EP EP86106521A patent/EP0202589B1/en not_active Expired - Lifetime
- 1986-05-15 PT PT82591A patent/PT82591B/pt not_active IP Right Cessation
- 1986-05-15 JP JP61111945A patent/JPH0739342B2/ja not_active Expired - Lifetime
- 1986-05-16 CA CA000509360A patent/CA1293728C/en not_active Expired - Lifetime
- 1986-05-16 HU HU862087A patent/HU197735B/hu not_active IP Right Cessation
- 1986-05-16 NO NO861956A patent/NO172343C/no unknown
- 1986-05-16 IE IE131386A patent/IE59143B1/en not_active IP Right Cessation
- 1986-05-16 ES ES555014A patent/ES8801643A1/es not_active Expired
- 1986-05-17 KR KR1019860003855A patent/KR940000073B1/ko not_active IP Right Cessation
- 1986-05-17 CN CN86103398A patent/CN1014409B/zh not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CN86103398A (zh) | 1986-12-03 |
| IE59143B1 (en) | 1994-01-12 |
| ZA852614B (en) | 1986-10-09 |
| KR940000073B1 (ko) | 1994-01-05 |
| PH24833A (en) | 1990-10-30 |
| IL78739A (en) | 1993-01-31 |
| NO172343B (no) | 1993-03-29 |
| AU5735086A (en) | 1986-11-20 |
| FI862029A (fi) | 1986-11-18 |
| KR860009001A (ko) | 1986-12-19 |
| PT82591A (en) | 1986-06-01 |
| JPS61263969A (ja) | 1986-11-21 |
| JPH0739342B2 (ja) | 1995-05-01 |
| NO172343C (no) | 1993-07-07 |
| EP0202589A3 (en) | 1987-10-07 |
| HU197735B (en) | 1989-05-29 |
| HUT44249A (en) | 1988-02-29 |
| AU599029B2 (en) | 1990-07-12 |
| PT82591B (pt) | 1988-11-30 |
| ES8801643A1 (es) | 1988-02-16 |
| EP0202589A2 (en) | 1986-11-26 |
| GR861228B (en) | 1986-09-15 |
| EP0202589B1 (en) | 1990-02-28 |
| FI862029A0 (fi) | 1986-05-14 |
| ES555014A0 (es) | 1988-02-16 |
| CA1293728C (en) | 1991-12-31 |
| IL78739A0 (en) | 1986-08-31 |
| CN1014409B (zh) | 1991-10-23 |
| IE861313L (en) | 1986-11-17 |
| DE3669104D1 (de) | 1990-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO861956L (no) | Fremgangsmaate for fremstilling av askorbinsyrederivater. | |
| NO163227C (no) | Fremgangsm te for fremstilling av 1-substituert-aryihydro-4-oksonaftyridin-derivater. | |
| NO874764D0 (no) | Fremgangsmaate for fremstilling av 2-aminopurinderivater. | |
| NO870579D0 (no) | Fremgangsmaate for fremstilling av indolizin-derivater. | |
| NO863061D0 (no) | Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater. | |
| NO862651D0 (no) | Fremgangsmaate for fremstilling av isoksazol- og furanderivater. | |
| NO865013D0 (no) | Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater. | |
| NO862861D0 (no) | Fremgangsmaate for fremstilling av distamycinderivater. | |
| NO171592C (no) | Fremgangsmaate for fremstilling av aktive cinnolin-derivater | |
| NO163453C (no) | Fremgangsmaate for fremstilling av sphingosinderivater. | |
| NO851920L (no) | Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater. | |
| NO860429L (no) | Fremgangsmaate for fremstilling av imidazolyl-indol-derivater. | |
| NO862687D0 (no) | Fremstilling av antibakterielle quinolonkarboksylsyrederivater. | |
| NO864525D0 (no) | Fremgangsmaate ved fremstilling av aryleddiksyrederivater. | |
| NO861652L (no) | Fremgangsmaate til fremstilling av n7-amidinosubstituerte mitomycin-c-derivater. | |
| NO874199D0 (no) | Fremgangsmaate for fremstilling av imidazo-pyridinonderivater. | |
| NO852796L (no) | Fremgangsmaate for fremstilling av nitroapovincamin-syrederivater. | |
| NO863769D0 (no) | Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid. | |
| NO864087D0 (no) | Fremgangsmaate for fremstilling av aroylthiazoloner. | |
| NO862493D0 (no) | Fremgangsmaate for fremstilling av 2-halonicergolinderivater. | |
| NO851319L (no) | Fremgangsmaate for fremstilling av eburnanderivater. | |
| NO874698L (no) | Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater. | |
| NO851195L (no) | Fremgangsmaate for fremstilling av askorbinsyreestere. | |
| NO873019D0 (no) | Fremgangsmaate for fremstilling av tetrahydrobenzotiazolkinolin-derivater. | |
| NO882493D0 (no) | Fremgangsmaate for fremstillng av kinolincarboxylsyrederivater. |